Our Science – Choyke Website
Peter L. Choyke, M.D.
Selected Publications |
 |
| 1)
Thomas A, Mena E, Kurdziel K, Venzon D, Khozin S, Berman AW, Choyke P, Szabo E, Rajan A, Giaccone G. 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors. Clin. Cancer Res. 19: 1487-93, 2013. [Journal] |
|
| 2)
Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H. Acute Cytotoxic Effects of Photoimmunotherapy Assessed by 18F-FDG PET. J. Nucl. Med. [Epub ahead of print], 2013. [Journal] |
|
| 3)
Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman Gerstein M, Piwnica-Worms K, Choyke P, Daryanani KT, Turkbey B, Fischer R, Bernardini I, Sincan M, Zhao X, Sandler NG, Roque A, Douek DC, Graf J, Huizing M, Bryant JC, Mohan P, Gahl WA, Heller T. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology. 144: 112-121.e2, 2013. [Journal] |
|
| 4)
Wood BJ, Choyke P, Turkbey B, Pinto P. Editorial comment. J. Urol. 189: 92, 2013. [Journal] |
|
| 5)
Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano. 7: 717-24, 2013. [Journal] |
|
| 6)
Kines RC, Kobayashi H, Choyke PL, Bernardo ML. Optical imaging of HPV infection in a murine model. Methods Mol. Biol. 961: 141-50, 2013. [Journal] |
|
| 7)
Nayak TK, Bernardo M, Milenic DE, Choyke PL, Brechbiel MW. Orthotopic Pleural Mesothelioma in Mice: SPECT/CT and MR Imaging with HER1- and HER2-targeted Radiolabeled Antibodies. Radiology. 267: 173-82, 2013. [Journal] |
|
| 8)
Seidel J, Xi W, Kakareka JW, Pohida TJ, Jagoda EM, Green MV, Choyke PL. Performance characteristics of a positron projection imager for mouse whole-body imaging. Nucl. Med. Biol. 40: 321-30, 2013. [Journal] |
|
| 9)
Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC. Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatr Blood Cancer. 60: 396-401, 2013. [Journal] |
|
| 10)
Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD. Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int. [Epub ahead of print], 2013. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/8/2013.
